BrightSpring Health Services (NASDAQ:BTSG) Given New $30.00 Price Target at UBS Group

BrightSpring Health Services (NASDAQ:BTSG) had its target price boosted by UBS Group from $22.00 to $30.00 in a research note issued on Wednesday,Benzinga reports. The brokerage currently has a “buy” rating on the stock. UBS Group’s price objective suggests a potential upside of 27.77% from the company’s current price.

Other equities analysts also recently issued reports about the stock. CJS Securities assumed coverage on shares of BrightSpring Health Services in a research note on Thursday, December 12th. They issued an “outperform” rating and a $27.00 price target on the stock. KeyCorp began coverage on BrightSpring Health Services in a research report on Friday, October 11th. They issued a “sector weight” rating for the company. Wells Fargo & Company increased their price target on shares of BrightSpring Health Services from $17.00 to $21.00 and gave the stock an “overweight” rating in a research report on Wednesday, November 27th. Bank of America lifted their price objective on BrightSpring Health Services from $19.00 to $21.00 and gave the stock a “buy” rating in a research report on Wednesday, December 11th. Finally, Morgan Stanley upped their price target on shares of BrightSpring Health Services from $19.00 to $20.00 and gave the company an “overweight” rating in a report on Tuesday, December 17th. One investment analyst has rated the stock with a hold rating and fourteen have given a buy rating to the company. According to data from MarketBeat.com, BrightSpring Health Services presently has an average rating of “Moderate Buy” and a consensus target price of $19.42.

BrightSpring Health Services Price Performance

Shares of NASDAQ BTSG traded up $0.75 during mid-day trading on Wednesday, reaching $23.48. The company had a trading volume of 82,949 shares, compared to its average volume of 1,604,001. BrightSpring Health Services has a 1-year low of $7.85 and a 1-year high of $23.81. The stock has a market cap of $4.09 billion and a PE ratio of -90.13. The company has a current ratio of 1.35, a quick ratio of 0.97 and a debt-to-equity ratio of 1.63. The company has a 50-day moving average price of $18.51 and a two-hundred day moving average price of $15.76.

BrightSpring Health Services (NASDAQ:BTSG) last posted its quarterly earnings data on Friday, November 1st. The company reported $0.11 EPS for the quarter, missing analysts’ consensus estimates of $0.18 by ($0.07). BrightSpring Health Services had a negative net margin of 0.38% and a positive return on equity of 4.16%. The firm had revenue of $2.91 billion for the quarter, compared to analysts’ expectations of $2.72 billion. The firm’s revenue was up 28.8% compared to the same quarter last year. On average, equities analysts anticipate that BrightSpring Health Services will post 0.59 earnings per share for the current year.

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of the company. R Squared Ltd bought a new position in shares of BrightSpring Health Services in the fourth quarter worth about $74,000. Intech Investment Management LLC purchased a new stake in shares of BrightSpring Health Services in the 3rd quarter worth $159,000. nVerses Capital LLC grew its position in shares of BrightSpring Health Services by 195.8% during the 3rd quarter. nVerses Capital LLC now owns 14,200 shares of the company’s stock worth $208,000 after buying an additional 9,400 shares in the last quarter. American Century Companies Inc. purchased a new position in shares of BrightSpring Health Services during the second quarter valued at $216,000. Finally, BNP Paribas Financial Markets raised its holdings in shares of BrightSpring Health Services by 5.0% in the third quarter. BNP Paribas Financial Markets now owns 21,329 shares of the company’s stock valued at $313,000 after acquiring an additional 1,011 shares in the last quarter.

About BrightSpring Health Services

BrightSpring Health Services, Inc operates a home and community-based healthcare services platform in the United States. The company's platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations.